Skip to main content
. 2016 Nov 29;8(1):1603–1612. doi: 10.18632/oncotarget.13688

Figure 4. Overall survival of normal karyotype IPSS-R higher risk patients with CNVs detected by MLPA (median OS: 17 months) and patients without CNVs (median OS: 48 months).

Figure 4